This video provides a comprehensive histopathological review of schwannoma (neurilemoma), a benign peripheral nerve sheath tumor. The presentation emphasizes the classic microscopic findings, including Verocay bodies, the biphasic architectural pattern of hypercellular Antoni A and hypocellular Antoni B areas, and characteristic changes like vascular hyalinization and hemorrhage/hemosiderin deposition. A crucial focus is placed on recognizing "ancient change"—scattered nuclear pleomorphism and atypia—which, despite its worrisome appearance, confirms a benign degenerative process within the schwannoma, preventing the overdiagnosis of malignancy (sarcoma). The video also explores rare and important variants, specifically plexiform schwannoma and the biologically aggressive melanotic schwannian tumor (formerly melanotic schwannoma), detailing the critical diagnostic and prognostic differences between schwannoma and neurofibroma, particularly regarding potential malignant transformation.
Schwannoma Histopathology and Differential Diagnosis
0:03 Introduction and Definition: Schwannomas (also known as Neurilemoma) are benign nerve sheath tumors composed almost entirely of Schwann cells (unlike neurofibromas, which contain a mix of cell types).
0:19 Classic Finding: Verocay Bodies: Verocay bodies are diagnostic of schwannoma, characterized by unique parallel palisaded rows of Schwann cells separated by an acellular space of fine pink collagen (cellular rarefaction).
Takeaway: Palisades can be seen in other tumors (e.g., leiomyomas, dermatofibromas), and not all schwannomas exhibit classic Verocay bodies; identification requires recognizing other features.
3:45 Gross Features and Capsule: Schwannomas arise from peripheral nerves, bulge out, and are typically surrounded by a thick, fibrous capsule (peri-neuron).
4:43 Architectural Zones (Antoni A and B): Schwannomas consist of two zones:
Antoni A (Hypercellular): The area where Verocay bodies are found (A and Verocay rhyme).
Antoni B (Hypocellular): Pales, less cellular areas with a myxoid or edematous (spaced out) background. Antoni B areas can be challenging to recognize and may resemble neurofibromas.
6:16 Common Findings (Hemorrhage & Vessels): Hemorrhage, hemosiderin (pigment from old blood), and macrophages are frequent. A key diagnostic clue is the presence of dilated vessels with thick, pink sclerotic/hyalinized collagen walls (7:00).
8:01 Hypercellularity and Malignancy: Features such as hypercellular fascicular growth (streaming patterns) are acceptable in a benign schwannoma.
Contrast: If these features are found in a neurofibroma, it raises significant concern for malignant peripheral nerve sheath tumor (MPNST) transformation; however, malignant transformation in schwannoma is extremely rare (9:01).
14:14 Degenerative Atypia ("Ancient Change"): Schwannomas often exhibit scattered nuclear pleomorphism (big, ugly, hyperchromatic nuclei). This is a benign, degenerative feature, sometimes termed Ancient Schwannoma (14:57), and should not be mistaken for malignancy, even in large retroperitoneal masses.
16:06 Immunostaining: The tumor should be diffusely positive for neural markers such as S-100 or Sox 10 (16:15).
22:46 Plexiform Schwannoma: An uncommon variant presenting with a multi-nodular/lobulated pattern microscopically.
Critical Distinction: Plexiform schwannoma does not associate with Neurofibromatosis Type 1 (NF1), unlike the plexiform neurofibroma (23:40).
26:22 Epithelioid Schwannoma: A rare subtype characterized by round, clustered, epithelioid Schwann cells. This can be misdiagnosed as epithelioid MPNST or melanoma if atypia/mitoses are present.
28:06 Melanotic Schwannian Tumor: Historically called Melanotic Schwannoma, this entity is characterized by strikingly atypical, pigment-laden cells. It is biologically aggressive/malignant and often associated with Carney Syndrome (29:58). The pathologist should explicitly include the word "malignant" in the diagnosis to guide clinical treatment.